QuidelOrtho Corp. Hits Day High with Strong 8.6% Intraday Surge

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge today, gaining 8.6% and reaching an intraday high of USD 17.10. This performance stands in contrast to the S&P 500, which saw a modest increase of 1.15% on the same day. Despite today's gains, QuidelOrtho has faced significant challenges over the past year, with a staggering decline of 53.94% compared to the S&P 500's 16.12% increase. The company's financial metrics reveal a concerning trend, with a debt-equity ratio of 138.72% and a low interest coverage ratio of 142.31, indicating potential financial strain. Over the last three years, QuidelOrtho has consistently underperformed against the benchmark, with a three-year performance decline of 80.57%. Additionally, the company has reported negative results for the last 12 consecutive quarters, further highlighting its ongoing difficulties. As it stands, QuidelOrtho's market capitalization is approximately USD 1,202 million, and it currently offers no dividend yield.